EXOME SEQUENCING OF EXTREME PHENOTYPES IDENTIFIES DCTN4 AS A MODIFIER OF CHRONIC PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS

被引:0
|
作者
Emond, M. J. [1 ]
Louie, T. [1 ]
Emerson, J. [2 ]
McNamara, S. [2 ]
Zhao, W. [1 ]
Mathias, R. [3 ]
Knowles, M. [4 ]
Wright, F. [4 ]
Rieder, M. [1 ]
Tabor, H. [2 ]
Nickerson, D. [1 ]
Barnes, K. [3 ]
Gibson, R. [2 ]
Bamshad, M. [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:277 / 277
页数:1
相关论文
共 50 条
  • [31] Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis
    Zhe Hui Hoo
    Elizabeth Coates
    Chin Maguire
    Hannah Cantrill
    Nadia Shafi
    Edward F. Nash
    Angela McGowan
    Stephen J. Bourke
    William G. Flight
    Thomas V. Daniels
    Julia A. Nightingale
    Mark I. Allenby
    Rachael Curley
    Martin J. Wildman
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 2219 - 2222
  • [32] Improvement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis
    Duncan, Rebecca P.
    Moustafa, Dina A.
    Lewin, Gina R.
    Diggle, Frances L.
    Bomberger, Jennifer M.
    Whiteley, Marvin
    Goldberg, Joanna B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (33)
  • [33] Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis
    Evans, Thomas J.
    FUTURE MICROBIOLOGY, 2015, 10 (02) : 231 - 239
  • [34] RISK FACTORS ASSOCIATED WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION IN A PEDIATRIC CYSTIC FIBROSIS POPULATION
    Terlizzi, V
    Galici, V
    Campana, S.
    Dolce, D.
    Ravenni, N.
    Taccetti, G.
    Braggion, C.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 317 - 318
  • [35] Novel mouse model of chronic pseudomonas aeruginosa lung infection mimicking cystic fibrosis
    Hoffmann, N
    Rasmussen, TB
    Jensen, PO
    Stub, C
    Hentzer, M
    Molin, S
    Ciofu, O
    Givskov, M
    Johansen, HK
    Hoiby, N
    INFECTION AND IMMUNITY, 2005, 73 (04) : 2504 - 2514
  • [36] Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany
    Naehrig, S.
    Schulte-Hubbert, B.
    Hafkemeyer, S.
    Hammermann, J.
    Dumke, M.
    Sieber, S.
    Naehrlich, L.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [37] Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis
    Hoo, Zhe Hui
    Coates, Elizabeth
    Maguire, Chin
    Cantrill, Hannah
    Shafi, Nadia
    Nash, Edward F.
    McGowan, Angela
    Bourke, Stephen J.
    Flight, William G.
    Daniels, Thomas V.
    Nightingale, Julia A.
    Allenby, Mark I.
    Curley, Rachael
    Wildman, Martin J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (11) : 2219 - 2222
  • [38] Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
    Lee, TWR
    Brownlee, KG
    Denton, M
    Littlewood, JM
    Conway, SP
    PEDIATRIC PULMONOLOGY, 2004, 37 (02) : 104 - 110
  • [39] Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Greally, Peter
    Whitaker, Paul
    Peckham, Daniel
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1059 - 1067
  • [40] Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection
    Coleman, FT
    Mueschenborn, S
    Meluleni, G
    Ray, C
    Carey, VJ
    Vargas, SO
    Cannon, CL
    Ausubel, FM
    Pier, GB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1949 - 1954